Gsa Capital Partners LLP Ginkgo Bioworks Holdings, Inc. Transaction History

Gsa Capital Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$0.28 - $1.16 $782,736 - $3.24 Million	2,795,488 New	2,795,488 $935,000
Q3 2023 Nov 15, 2023	BUY	$1.61 - $2.54 $122,316 - $192,971	75,973 New	75,973 $137,000
Q1 2023 May 12, 2023	SELL	$1.2 - $2.19 $54,490 - $99,445	-45,409 Reduced 38.47%	72,615 $96,000
Q4 2022 Feb 13, 2023	BUY	$1.63 - $3.52 $19,683 - $42,507	12,076 Added 11.4%	118,024 $199,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $3.74 $100,647 - $515,645	-137,873 Reduced 56.55%	105,948 $331,000
Q2 2022 Aug 09, 2022	BUY	$2.2 - $4.2 $536,406 - $1.02 Million	243,821 New	243,821 $580,000
Q1 2022 May 11, 2022	SELL	$2.83 - $8.69 $74,828 - $229,772	-26,441 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $219,724 - $394,499	26,441 New	26,441 $220,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.